Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

stockvadar 158 posts  |  Last Activity: 2 hours 50 minutes ago Member since: Sep 20, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • It's bizarre how this gem could be down with so many great revenue stories told by Nam and Loko. WE follow these posters and hang on their every words. So much truth!

    -sv (STRONG BUY)

    Sentiment: Strong Buy

  • Why this isn't over $3 is a mystery. Loko has been telling us about the many revenue generating opportunities and it seems very EXCITING.

    -sv (STRONG BUY)

    Sentiment: Strong Buy

  • This should already be over one dollar if not higher. They've got so much going right and so many great posts by Loko proving the awesome value of this company.

    -sv (Strong Buy)

    Sentiment: Strong Buy

  • Could soar well above $1 any minute now!

    -sv (STRONG BUY)

    Sentiment: Strong Buy

  • Reply to

    Stockvadar just for your information

    by nammuang May 22, 2016 10:41 PM
    stockvadar stockvadar May 22, 2016 11:35 PM Flag

    ha'

    off to 60 NAM

  • Reply to

    Tappy20#4 post recap, Stockvadar-helps

    by stockvadar May 21, 2016 8:38 PM
    stockvadar stockvadar May 22, 2016 9:18 PM Flag

    Investors,

    We too like Nam once bought into the
    Antares promise as we continue to
    look for a future success after a history
    of valiant tries.

    But we must warn you about the false
    hope Loko's been promoting about an
    early-generic version of Epi, as if it's
    definitely going to happen. Quite truthfully,
    he's dead wrong, just as he was about
    false hopes regarding the Population
    Council. The Population Council has
    been dead for years, but Loko went on
    promoting it, deceiving many. Now Nam
    picks up a generic Epi because he's
    read a trademark of which there are
    many.

    There are always many trademarks and
    that proves nothing. Teva has filed many
    many trademarks and all that means is that
    there are trademarks. Not one of them
    suggests Teva is changing course and it's
    a real shame that Loko promotes this
    lie supported by Nam.

    The facts are, Antares is scrambling to
    get Oxtrexup from flat-lining because that's
    what has been going on for six long months.

    We want to be optimistic but optimism isn't
    built on lies. Antares Execs want 100M shelf
    shares for a reason and we know it. They
    intend to use those 100M shares and if
    necessary will reverse split the stock to
    regain compliance.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • Investors,

    We really thought our partnership with
    Ferring would help us move to profitability
    but it didn't.

    We hung our hopes on Elestrin and a
    partnership with Population Council but it
    never amounted to anything.

    We then shifted our hopes to Gelnique
    thinking that millions of seniors would be
    helped, but it never happened.

    So we looked at the partnership with Pfizer
    but the deal completely fell apart.

    So we turned our hopes on Oxtrexup. After
    all, the CEOs said it would move the
    company to profitability, now we know
    different.

    So now we're holding out hope for a Teva
    partnership that is delayed. Of course, Leo
    dumping us is all over, no big deal.

    We're also holding out hope for a T injector
    that is also likely to be delayed and competition
    is growing.

    But no bother. Antares is great at adding VPs
    and hiring new CEOs. Let's get excited about
    the shrinking cash position because soon
    enough we'll be able to tap 100M shelf shares
    even though it will dilute shareholders. If we
    have too, a reverse split.

    Awesome.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • stockvadar stockvadar May 17, 2016 8:58 PM Flag

    Not really. Most left here bought over $3. This is like an episode from the WALKING DEAD.

    As for our Consortium, We'll sit back and watch this fade lower. After all, it's still over-priced when the CEO, BOD, and VPs are overpaid.... 100M shelf shares.... and Oxtrexup is a sales flop.

    Companies like this go for 15 cents big boy. You've yet to see this fall. We're told that "Making Medicines Feel Better" is a COMPLETE FLOP WITH INSURERS. Maybe someone will figure this out.

    Most likely, our consortium will never buy again unless something major happens. This smells like a broken stock of a company that NEVER ACHIEVED.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • Reply to

    Won 6k tonight boys!

    by rymankly May 15, 2016 6:19 PM
    stockvadar stockvadar May 15, 2016 6:24 PM Flag

    Yer lying. Yer mommy said.

  • If you truly think this CB2 drug candidate has a chance, think again. The Arena Titanic is heading straight for disaster and when it hits, the stock will plunge.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • Reply to

    Got 2k on the Heat/Raptors game today

    by rymankly May 15, 2016 3:31 PM
    stockvadar stockvadar May 15, 2016 4:03 PM Flag

    You'll probably lose because you're a L@SER. HAHA

  • Oxtrexup was FLAT in Q4 2015. Oxtrexup was FLAT in Q1 2016. And most likely April 2016, but we'll leave that fact aside to point out: IT'S BEEN FLAT FOR SIX MONTHS!

    That is REALLY BAD NEWS for a product that was supposed to make the company profitable.

    Since everyone seems to want to be the first to claim saying (e.g. Loko), we'll claim that "Making Medicines Feel Better" is a MAJOR SALES FLOP with insurers. Insurers want what is cheap and the Vibex is far from cheap and therefore will never gain insurer buy-in.

    Perhaps someone will start a SYRINGE COMPANY with the logo, "NO PAIN NO GAIN!"

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • stockvadar stockvadar May 15, 2016 3:49 PM Flag

    Answer? Ryman asked Tappy a direct question about shelf shares. Tappy didn't answer.

    Our consortium is hardly a room fool of cowards. WE'll watch this failing company fall lower and lower and we'll do whatever is correct to trade in and out for profits.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • Tayppy's a c@ward. He won't answer. A 1/3 dilution.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • Reply to

    The TAPPY-TRUTH about Antares, Stockvadar-reports

    by stockvadar May 12, 2016 10:18 PM
    stockvadar stockvadar May 12, 2016 10:28 PM Flag

    Desperate Nam,

    Nam can't stand to let a post go by. After all,
    Nam's account is shrinking lower and lower,
    so he reaches out in desperation.

    Sell Nam, before Antares RS splits your
    small holdings. Antares is a sewer.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • Investors,

    Going on two decades, Antares is not profitable.

    Elestrin failed. Gelnique failed. And Oxtrexup is
    failing. Ferring? What's to say?

    What's worse, "Making Medicines Feel Better" is
    being rejected by insurance companies. The
    high cost makes Oxtrexup, Testosterone, and "M"
    dead in the water.

    What's scary is, the above principle holds true for
    the Teva partnership. Pain-free at a premium is not
    being supported by insurance companies, and
    thereby, the doctors who write the scripts.

    Meanwhile, Antares has hired VPs going out the
    you-know-what, and the CEO and BOD get free
    shares while relishing in another 100M dilution
    shares.

    Unfortunately in 2016, investors will feel the
    Russell dump, the pressure to RS to stay on
    the NASDAQ, and the pressures of shrinking
    capital because revenue is going to plunge in
    Q3. That's what Antares Execs failed to say,
    but everyone knows that it's true.

    Sadly, we must tell investors to expect Antares
    to fall to very low levels. Expect it to test the 52
    week low, and then go lower. If we buy, we'll buy
    on the cheap to flip. This company is in deep
    trouble overloaded by a high paid CEO and a
    list of VPs that will make you puke. Their failure?
    Oxtrexup. It NEVER TOOK OFF.

    BTW, when we read Loko's post about fantasy
    Epi, we laugh. We could cry, but poor Loko is
    a loser investor struggling to find reason for
    why he hung in here. We never liked him.

    -sv (STRONG SELL, STAY AWAY)

    Sentiment: Strong Sell

  • stockvadar stockvadar May 12, 2016 9:59 PM Flag

    Nam is a rather amateurish investor. Desperate. Unfortunately, he's watching the pps decline and is sick tonight thinking it's in deathspiral.

    Just remember Nam, WE have NOTHING to do with Antares' repeated failures. But WS and HFs see the facts and it's ugly. Fat cat CEO, VPs, and BOD collecting Y/Y, while little Nam whines.

    The company is in deathspiral. We've seen it before and you're seeing it now. Declining revenues and product failure; it's the recipe for a company heading towards DISASTER.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • stockvadar stockvadar May 12, 2016 8:38 PM Flag

    Times change and this time for the worst. Get over yourself. The pps is in deathspiral and 72 cents won't hold. Sometimes you have to change your mind.

    Our consortium listened to the CC and someone said, "Boy, are those high-paid Execs blowing a lot of smoke!" We all laughed because we knew what it meant.

    Antares is in big trouble. Talk to a doc. Oxtrexup is an expensive option and insurance companies want docs to write scripts for cheaper options. Hate to tell you this, but "Making Medicines Feel Better" is not being justified by the insurance companies. Next stop. Testosterone, it will hit the same problem.

    Analysis: Antares is selling and developing injectors the insurance companies (and docs) are unwilling to pay for -- now put that in your pipe and smoke it.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

  • 81 cent close. 82 cent didn't hold. Tough situation. Looks like the CEO, BOD, and VPs will be under water with that 72 cent buy in jeopardy. We're LOOKING FORWARD TO IT. Down, down, down it goes! Soon to test the 52 week bottom. So what?

    Dumped by Russell.
    Dilution inevitable (100 Shelf Share)
    Delisting by NASDAQ (May cause a RS)

    Down, down, down! And why? Because Oxtrexup is joining the other flunkies. And EPI's DELAYED, DELAYED, DELAYED. So many negative knowing that they're losing a lot of revenue in Q3. Just a bad situation all around.

    Lots of DEPRESSION on this YB. Enterprise value will soon fall below $100M.

    What a DISAPPOINTMENT!

    -sv (Yup)

    Sentiment: Strong Sell

  • stockvadar stockvadar May 10, 2016 9:52 PM Flag

    The flow of information day-to-day requires a savvy repostering otherwise you will be eaten alive. Our recourse is based on the CC and recent airings of one Loko and others who uniformly concur that Antares is in deep trouble and so, the wind is now BEARISH. Unfortunately for those unwilling to suffer losses, it does appear the company will set a new low followed by a series of dilution(s) and even a RS.

    The sane approach is simply to warn others unless Antares can pull a rabbit out of its hat. Something that in two decades is yet to happen. It would not surprise us to see Antares fall below 50 cents based on Q1's poor performance to turn Oxtrexup around.

    -sv (STRONG SELL)

    Sentiment: Strong Sell

ARRY
3.48+0.12(+3.57%)May 26 4:00 PMEDT